Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Priming”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01804413
What this trial is testing

Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency

Who this might be right for
Adults Growth Hormone Deficiency.
Oregon Health and Science University 10
Not applicableLooking for participantsNCT06938945
What this trial is testing

Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial

Who this might be right for
Hepatocellular Carcinoma (HCC)
Wei Xiaoping 500
Not applicableStudy completedNCT05348395
What this trial is testing

Monocyte Priming When Consuming a Western Diet

Who this might be right for
Heart Diseases
Wake Forest University Health Sciences 8
Testing effectiveness (Phase 2)Study completedNCT01101880
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+8 more
University of Washington 50
Not applicableStudy completedNCT00978588
What this trial is testing

Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

Who this might be right for
Mitral Valvular Heart Disease
Yonsei University 36
Not applicableStudy completedNCT05214209
What this trial is testing

Diabetes Prevention and Prediabetes Management in Adult

Who this might be right for
PreDiabetes
Monash University 10
Large-scale testing (Phase 3)Study completedNCT01900899
What this trial is testing

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

Who this might be right for
Infections, Meningococcal
Pfizer 184
Testing effectiveness (Phase 2)Study completedNCT00140387
What this trial is testing

Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)

Who this might be right for
Prostate Cancer
Cell Genesys 20
Testing effectiveness (Phase 2)Ended earlyNCT04190056
What this trial is testing

Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8
University of California, San Francisco 1
Not applicableLooking for participantsNCT06954194
What this trial is testing

Syntactic Intervention for Cantonese-speaking Children With DLD

Who this might be right for
Developmental Language Disorder
The Hong Kong Polytechnic University 32
Not applicableStudy completedNCT04239677
What this trial is testing

Impact of Retrograde Autologous Priming on the Coagulation Profile Assessed by Rotation Thromboelastometry (ROTEM) in Patients Undergoing Cardiac Surgery

Who this might be right for
Cardiac SurgeryVascular Surgery Using CPB
Yonsei University 104
Not applicableUnknownNCT05769894
What this trial is testing

Platelet Reactivity in Non-cardiac Inflammation A Prospective Observational Single Centre Study.

Who this might be right for
Inflammatory ResponsePlatelet Aggregation, Spontaneous
University Hospital Southampton NHS Foundation Trust 100
Early research (Phase 1)Study completedNCT01373879
What this trial is testing

AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic Area

Who this might be right for
Malaria
University of Oxford 52
Early research (Phase 1)Study completedNCT00374998
What this trial is testing

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

Who this might be right for
Malaria, FalciparumMalaria
European Vaccine Initiative 35
Not applicableLooking for participantsNCT07635316
What this trial is testing

Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Novartis Pharmaceuticals 4,023
Not applicableActive Not RecruitingNCT07287072
What this trial is testing

Pain Reprocessing Therapy for Chronic Primary Pain

Who this might be right for
Nociplastic PainChronic Primary Pain
University of Oslo 12
Testing effectiveness (Phase 2)Study completedNCT02935686
What this trial is testing

A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 155
Testing effectiveness (Phase 2)Looking for participantsNCT05799144
What this trial is testing

PBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

Who this might be right for
Metastatic Oropharyngeal CarcinomaRecurrent Oropharyngeal Carcinoma
Michael K. Gibson 54
Large-scale testing (Phase 3)Study completedNCT00944034
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,588
Not applicableStudy completedNCT05210309
What this trial is testing

National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study)

Who this might be right for
SafetyEfficacy, Self
Universidad de Zaragoza 63
Next Page